February 1, 2021
The Pharmaceuticals and Medical Devices Agency (PMDA) is investigating new side effect risks for 45 non-steroidal anti-inflammatory drug (NSAID) products, a move likely to trigger label changes in the near future. According to the agency’s risk communication update on January...read more